SCHEMBL8990313

SCHEMBL8990313

CCCOC(CO)(CO)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
CHRM2 P08172 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
MLNR O43193 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
OPRK1 P41145 1/20 0.38
HTR2B P41595 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
CACNA1C Q13936 1/20 0.38
KIF11 P52732 1/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 1/20 0.38
HPGD P15428 1/20 0.37
KCNN4 O15554 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8990316 0.86 ALDH1A1 (0.39) LMNAKIF11ALDH1A1ALOX15KCNN4
SCHEMBL27284232 0.78 LMNA (0.40) LMNACHRM2CHRM1CHRM3MLNR
SCHEMBL8990308 0.77 CES1 (0.42) CHRM3KIF11ALDH1A1ALOX15KCNN4
SCHEMBL7943850 0.76 KDM4E (0.46) LMNACHRM2CHRM1CHRM3OPRM1
SCHEMBL720308 0.75 CNR1 (0.36) MEN1KMT2ATSHRSIGMAR1
SCHEMBL13320030 0.75 LMNA (0.45) LMNACHRM2CHRM1CHRM3MLNR
SCHEMBL2348691 0.74 KIF11 (0.65) LMNACHRM2CHRM1CHRM3MLNR
SCHEMBL6421037 0.74 KIF11 (0.43) LMNACHRM2CHRM1CHRM3MLNR
SCHEMBL8434800 0.74 KIF11 (0.43) LMNACHRM2CHRM1CHRM3MLNR
SCHEMBL1356738 0.73 ALDH1A1 (0.43) LMNACHRM2CHRM1CHRM3MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137592-A1 PROCESS FOR PREPARING PURINE DERIVATIVE AUROBINDO PHARMA LTD (IN) 2010-06-03 US disclosed
US-5500484-A FROM ALDEHYDE KURARAY CO., LTD. (JP) 1996-03-19 US disclosed
EP-0641757-A1 2-Aryl-1,3-propanediol and dioxane derivatives and their preparation KURARAY CO., LTD. (JP) 1995-03-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137592-A1 PROCESS FOR PREPARING PURINE DERIVATIVE TYMP, PNP, UMPS LMNA 1185/4885CHRM2 4666/4885CHRM1 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.